AR and posterior cortical atrophy: AR antagonism induces reprograming of lipid metabolism through lowered FASN expression, thereby decreasing intracellular saturated FA levels and promoting uptake of nutrient derived polyunsaturated FAs (PUFAs) in PCa [245,383,384].